Leukotriene B4 up-regulates IL-6 rather than IL-1 synthesis in human monocytes

P E Poubelle1, J Stankova, J Grassi

  • 1Unité de Recherche Inflammation et Immunologie-Rhumatologie, Centre de Recherche du CHUL, Boul Laurier, Québec, Canada.

Agents and Actions
|September 1, 1991
PubMed

Insights

Leukotriene B4 (LTB4) primarily boosts Interleukin-6 (IL-6) production in monocytes, enhancing thymocyte responses. This effect is mainly driven by increased IL-6, not IL-1, in LTB4-treated monocytes.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Leukotriene B4 (LTB4) is a lipid mediator involved in inflammatory responses.
  • The role of LTB4 in modulating cytokine production, particularly Interleukin-6 (IL-6) and Interleukin-1 (IL-1), requires further clarification.
  • Monocytes play a crucial role in immune responses, including T cell activation.

Purpose of the Study:

  • To investigate the specific effects of LTB4 on the production of IL-6 and IL-1 by monocytes.
  • To determine the contribution of LTB4-induced cytokines to the costimulatory activity of monocyte supernatants on thymocytes.

Main Methods:

  • Monocytes were treated with LTB4, and IL-6 and IL-1 mRNA and protein levels were assessed.
  • Enzyme-linked immunosorbent assay (ELISA) and B9 cell bioassay were used to quantify cytokine release.
  • Thymocyte costimulatory activity of monocyte supernatants was measured, with and without anti-IL-1 antibody.

Main Results:

  • LTB4 significantly increased IL-6 mRNA accumulation and protein release.
  • LTB4 induced minimal IL-1 mRNA or protein, even with muramyl dipeptide.
  • Monocyte supernatants from LTB4-treated cells showed enhanced thymocyte costimulatory activity, largely blocked by anti-IL-1 antibody.
  • Baseline IL-1 was sufficient for synergistic thymocyte stimulation with IL-6.

Conclusions:

  • LTB4 preferentially stimulates IL-6 production in monocytes.
  • The enhanced thymocyte response to LTB4-treated monocyte supernatants is primarily due to increased IL-6 levels, alongside baseline IL-1 levels.